Browse > Article

Bone Mineral Density and Bone Markers in the Children with Epilepsy Taking on Chronic Anticonvulsants  

Lee, Soon Bum (Department of Pediatrics, College of Medicine, Dankook University)
Kang, So Young (Department of Pediatrics, College of Medicine, Dankook University)
Yu, Jeesuk (Department of Pediatrics, College of Medicine, Dankook University)
Publication Information
Clinical and Experimental Pediatrics / v.48, no.5, 2005 , pp. 527-533 More about this Journal
Abstract
Purpose : Long-term administration of anticonvulsants in children with epilepsy may cause short stature, hypocalcemia and low bone mineral density. This study was performed for the early detection of abnormal bone metabolism in children with epilepsy on taking anticonvulsants. Methods : Thirty children aged 5 to 16 years who were diagnosed with epilepsy were enrolled in this study. All had taken anticonvulsants for more than one year. Bone mineral density of lumbar vertebra was measured by dual-energy X-ray absorptiometry. Serum calcium, phosphorous, alkaline phosphatase, 25-hydroxycholecalciferol[$25(OH)D_3$], parathyroid hormone, and urine deoxypyridinoline were measured as biochemical bone markers. Bone age and body mass index were also calculated. Results : Bone minreal density, body mass index, bone age, and height were significantly decreased in two female patients who had taken two antiepileptic drugs for more than four years and they also had chronic diseases such as cerebral palsy with microcephaly, encephalomalacia, and microcephaly with atrial septal defect. Bone mineral density had significant positive correlations with body mass index(P<0.01) and bone age(P<0.01). Conclusion : This study showed chronic medication of anticonvulsants in children may cause low bone mineral density and short stature. Bone age and body mass index could be the important surrogate markers to find the population at risk. More studies, including a large study population and long term cohort study, will be required.
Keywords
Bone mineral density; Bone markers; Child; Epilepsy; Anticonvulsants;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Paul LK, Donal EO, Banta D, Feinstein AR, Frazier HS, Hronick Richard, et al. Radiologic methods to evaluate bone mineral content. Health and Public Policy Committee, American College of Physicians. Ann Intern Med 1984;100: 908-11   DOI   ScienceOn
2 Delmas PD. Biochemical markers of bone turnover. J Bone Miner Res 1993;8:549-55
3 Riggs BL, Melton LJ 3rd. Involutional osteoporosis. N Engl J Med 1986;314:1676-86   DOI   ScienceOn
4 Kim TJ, Suh ES. Bone mineral density in epileptic children who received long-term anticonvulsant drugs. J Korean Child Neurol 1997;5:52-8
5 Timperlake RW, Cook SD, Thomas KA, Harding AF, Bennett JT, Haller JS et al. Effect of anticonvulsant drug therapy on bone mineral density in a pediatric population. J Pediatr Orthop 1988;8:467-70   DOI
6 Livingston S, Berman W, Pauli LL. Anticonvulsant drugs and vitamin D metabolism. JAMA 1973;224:1634-5   DOI   ScienceOn
7 Hahn TJ, Hendin BA, Scharp CR, Haddad Jr. Effect of chronic anticonvulsant therapy on serum 25-hydroxycalciferol levels in adults. N Engl J Med 1972;287:900-4   DOI   ScienceOn
8 Hann TJ, Birge SJ, Scharp CR, Avioli LV. Phenobarbital-induced alterations in vitamin D metabolism. J Clin Invest 1972:51:741-8   DOI
9 Boot AM, de Ridder MA, Pols HA, Krenning EP, de Muinck Keizer-Schrama SM. Bone mineral density in children and adolescents: relation to puberty, calcium intake, and physical activity. J Clin Endocrinol Metab 1997;82:57-62   DOI   ScienceOn
10 Andress DL, Ozuna J, Tirschwell D, Grande L, Johnson M, Jacobson AF, et al. Antiepileptic drug-induced bone loss in young male patients who have seizures. Arch Neurol 2002; 59:781-6   DOI   ScienceOn
11 Eyre DR, Dickson IR, Van Ness K. Collagen cross-linking in human bone and articular cartilage. Age-related changes in the content of mature hydroxypyridinium residues. Biochem J 1988;252:495-500   DOI
12 Chung HY, Jang HC, Kim CJ, Min YK, Moon IG, Han IK.Urinary pyridinium cross links as bone markers in postmenopausal osteoporosis. J Korean Soc Bone Metabol 1994; 1:34-9
13 Heller HJ, Sakhaee K. Anticonvulsant-induced bone disease: a plea for monitoring and treatment. Arch Neurol 2001;58:1352-3   DOI   ScienceOn
14 Schimid F. Osteopathien bei antiepileptischer daurbehandlung. Fortscher Med 1967;95:381-2
15 Crosley CJ, Chee C, Berman PH. Rickets associated with long-term anticonvulsant therapy in a pediatric outpatient population. Pediatrics 1975:56:52 -7
16 Ala-Houhala M, Korpela R, Koivikko M, Koskinen T, Koskinen M, Koivula T. Long-term anticonvulsant therapy and vitamin D metabolism in ambulatory pubertal children. Neuropediatrics 1986;17:212-6   DOI   PUBMED
17 Dent CE, Richens A, Rowe DJ, Stamp TC. Osteomalacia with long-term anticonvulsant therapy in epilepsy. BMJ 1970;4:69-72   DOI
18 Moss DW. Alkaline phosphatase isoenzymes. Clin Chem 1982;28:2007-16
19 Koch HV, Kratf D, von Herrath D. Influence of diphenylhydantion and phenobarbital on intestinal calcium transport in the rat. Epilepsia 1972;13:829-34   DOI   ScienceOn
20 Finsen V, Anda S. Accuracy of visually estimated bone mineralization in routine radiographs of the lower extremity. Skeletal Radiol 1988;17:270-5   DOI   ScienceOn
21 Farhat G, Yamout B, Mikati MA, Demirjian S, Sawaya R, El-Hajj F. Effect of antiepileptic durgs on bone density in ambulatory patients. Neurology 2002:58:1348-53   DOI   ScienceOn
22 Suh YS, Kim YG, Lee JH, Yoo KH, Lee JW, Tockgo YC. The effect of long-term phenobarbital administration on the bone mineral density of children. J Korean Pediatr Soc 1994;37:368-75
23 Cho YW, Lee IK, Seung HH. Adverse effects of antiepilep tic drugs on bone mineral density in women with epilepsy. Korean J Endocrinol 2002;17:218-25
24 Weinstein RS, Bryce GF, Sappington LJ, King DW, Gallagher BE. Decreased serum ionized calcium and normal vitamin D metabolite levels with anticonvulsant drug treatment. J Clin Endocrinol Metab 1984:58:1003-9   DOI
25 Jubiz W, Haussler MR, McCain TA, Tolman KG. Plasma 1,25-dihydroxyvitamin D levels in patients receiving anticonvulsant drugs. J Clin Endocrinol Metab 1977;44:617-21   DOI
26 Oh HH, Jang YC, Choe BH, Park IH, Kwon SH. Effect of the chronic use of antivonculsants on bone mineral density in children with epilepsy. Korean J Pediatr 2004:47:965-9
27 Hunter J, Maxwell JD, Stewart DA, Parsons V, Williams R. Altered calcium metabolism in epileptic children on anticonvulsants. BMJ 1971;4:202-4   DOI
28 Tsutsumi H, Katagiri K, Morimoto M, Nasu T, Tanigawa M, Mamba K. Diurnal variation and age-related changes of bone turnover markers in female Gottingen minipigs. Lab Anim 2004;38:439-46   DOI   ScienceOn
29 Matkovic V, Jelic T, Wardlaw GM, Llich JZ, Goel PK, Wright JK, et al. Timing of peak bone mass in Caucasian females and its implication for the prevention of osteoporosis. J Clin Invest 1994;93:799-808   DOI   ScienceOn
30 Juhng WS, Kim SJ, Cho SC, Joo CU. Effect of antiepiletpic drugs on bone metabolism and growth in epileptic children. J Korean Pediatr Soc 1999:42:1078-85
31 Kim BY, Kim YG, Kim YJ, Yoo KH, Lee JW, Kim SK. A study of bone mineral density in korean children of normal growth and development. J Korean Pediatr Soc 1995;38: 612-8
32 Drezner MK. Treatment of anticonvulsant drug-induced bone disease. Epilepsy Behav 2004;5:41-7   DOI   ScienceOn